Z.M. Younossi

6 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELATED MORTALITY

J.P. Ong, Andrew F. Pitts, Z.M. Younossi · Journal of Hepatology · 2008 · 119 citations

Medicine, Pathobiology, Hepatology +8

Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

Arun J. Sanyal, Vlad Ratziu, Rohit Loomba et al. · Journal of Hepatology · 2023 · 117 citations · Full text

Medicine, Pathology, Pharmacology +17

Non-alcoholic fatty liver disease and hepatitis C infection.

Silvia Bondini, Z.M. Younossi · PubMed · 2006 · 50 citations

Medicine, Pathobiology, Pathology +17

An Open-label Pilot Trial of Cladibrine (2-Chlorodeoxyadenosine) in Patients with Primary Sclerosing Cholangitis

Andrea Duchini, Z.M. Younossi, Alan Saven et al. · Journal of Clinical Gastroenterology · 2000 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +10

5 REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTION IN PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · Journal of Hepatology · 2011 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14